Testing for Mental Illness
The GeneSight Psychotropic Test analyzes how your genes affect your response to psychotropic medications commonly prescribed to treat depression, anxiety, bipolar disorder, posttraumatic stress disorder (PTSD), obsessive compulsive disorder, schizophrenia and other behavioral health conditions. There are dozens of medications used to treat depression and other mental illnesses and selecting the right antidepressant medication or other medication can be a challenging and frustrating process. GeneSight Psychotropic’s genetic testing enables your clinician to identify and avoid depression, anxiety and/or other medications that are unlikely to work or may cause side effects.
The Genecept Assay® is a genetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. It identifies patient-specific genetic markers that indicate which treatments are likely to work as intended, have no effect, or cause adverse effects. It is an easily administered cheek swab test that analyzes key genes, selected based on hundreds of studies showing that variations in these genes can inform treatment decisions.
Genecept is used to guide treatment for a range of psychiatric conditions, including depression, anxiety, attention deficit hyperactivity disorder (ADHD) and more.
Genecept has been shown in peer reviewed published studies to improve patient outcomes and reduce overall medical costs. Each test provides clinicians with an easy to read patient report and a complimentary psychopharmacogenomic consultation.